Up to 50% of patients with mental disorders do not respond to the available psychiatric treatments. Despite rising rates of ...
Germany is the first EU country to establish a compassionate psilocybin use program — a regulated expanded-access pathway ...
Everything in moderation. Including moderation. That’s the idea behind the Colorado sober movement, an unofficial yet growing ...
Benjamin Lightburn, CEO of Filament, is pictured. A recent boom in psychedelic research has given way to a bumper crop of startups seeking to harness the potential of mind-altering drugs for treating ...
In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, ...
A new study shows that the use of psilocybin, a compound found in the widely known 'magic mushrooms,' initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and ...
Zalsupindole is an analogue of 5-MeO-DMT, a psychedelic drug derived from desert toad secretions. The company reported a ...
In recent years, strides have been made in better understanding the potential benefits of psychedelics for mental health conditions. However, most of these substances are still classified as Schedule ...
A recent boom in psychedelic research has given way to a bumper crop of startups seeking to harness the potential of mind-altering drugs for treating depression, addiction and other conditions. In ...